Novavax COVID-19 vaccine shows 90.4% efficacy in late stage trial
(Photo by JUSTIN TALLIS / AFP) Novavax Inc on Monday (June 14) reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19…
